(Q39369222)

English

The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

object named as

Walter Akers

6

0 references

Samuel Achilefu

object named as

Samuel Achilefu

7

0 references

author name string

Zhenzhen Tu

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hui Li

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yuxiang Ma

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Bin Tang

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Junmei Tian

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yueqing Gu

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

4 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Molecular and Cellular Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

366

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

111-122

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Mechanisms of tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Antiproliferative effect of trichostatin A and HC-toxin in T47D human breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Histone deacetylase inhibitor induced modulation of anti-estrogen therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Estrogen receptor beta in breast cancer--diagnostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Histone deacetylase inhibition and estrogen signalling in human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Minireview: nuclear receptor coactivators--an update

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Selective inhibition of histone deacetylase 2 silences progesterone receptor-mediated signaling

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

ERalpha and ERbeta expression and transcriptional activity are differentially regulated by HDAC inhibitors.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

The effects of histone acetylation on estrogen responsiveness in MCF-7 cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Formation of the androgen receptor transcription complex

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

PPARgamma controls cell proliferation and apoptosis in an RB-dependent manner

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Raloxifene, a selective estrogen receptor modulator, induces mitochondria-mediated apoptosis in human endometrial carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Histone deacetylase as a therapeutic target

1 reference

https://api.crossref.org/works/10.1007%2FS11010-012-1288-9

21 January 2018

Pregnancy-associated inhibition of coronary artery atherosclerosis in monkeys. Evidence of a relationship with endogenous estrogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Species-specific pharmacology of antiestrogens: role of metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of estradiol on accelerated atherosclerosis in rabbit heterotopic aortic allografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Raloxifene and selective cell cycle specific agents: a case for the inclusion of raloxifene in current breast cancer treatment therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The search for cytotoxic synergy between anticancer agents: a case of Dorothy and the ruby slippers?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Raloxifene works as well as tamoxifen in preventing invasive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular and molecular pharmacology of antiestrogen action and resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/22476901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11010-012-1288-9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39369222&oldid=2202813919"